Takayasu's Arteritis from the Patients' Perspectives: Measuring the Pulse to the Patient-Reported Outcomes

Abstract

Patients with Takayasu's arteritis (TA) experience important changes in lifestyle, quality of life, and functional status due to ischemic symptoms or treatment toxicity. To describe the clinical characteristics and the patient-reported outcomes (PROs), such as quality of life, disability, fatigue, and perception/impact of the disease in Mexican patients with TA. Cross-sectional study including patients with established diagnosis of TA recruited at a tertiary care center. Demographics, comorbidities, clinical characteristics, laboratory, imaging, and treatment were retrieved. Disease activity (the Indian Takayasu Clinical Activity Score (ITAS) 2010), damage (Vasculitis Damage Index (VDI)), quality of life (Short Form 36 (SF-36)), disability (Health Assessment Questionnaire Disability Index (HAQ-DI)), fatigue (Multidimensional Fatigue Inventory-20), and patient's disease perceptions were assessed. Fifteen women were included, with a median age of 41years (interquartile range (IQR) 30-45) and disease duration of 108months (IQR 55-197). Median ITAS 2010 and VDI scores were 0 (IQR 0-2) and 3 points (IQR 2-6), respectively. Mean SF-36 score was 71.38±13.39, with mean physical and mental component summaries of 66.52±13.37 and 76.24±14.89, respectively. HAQ-DI mean score was 0.48±0.62, being grip the most affected domain. Among fatigue subscales, the higher scores were present in the physical fatigue (16.3±5.8). Correlations between the HAQ-DI and the VDI score (r=0.64, P=0.03); between the general fatigue, score, and disease duration (r=-0.71, P=0.01); and between the SF-36 total score and the HAQ-DI (r=-0.87, P=0.0004) were found. It is important to identify disease-specific outcomes of interest to the patients to develop tools that assess them with a holistic approach.